Researchers have found in a new study that Metabolic and bariatric surgery was associated with an approximately 50% reduction in the risk of adverse kidney outcomes among patients with obesity, irrespective of the presence of type 2 diabetes. Findings published in Obesity Science & Practice suggest that bariatric surgery may help preserve kidney function in obese patients both with and without type 2 diabetes.
Obesity is associated with an increased risk of chronic kidney disease. Metabolic and bariatric surgery (MBS) is currently the most effective intervention for sustained weight loss and may reduce the risk of obesity-associated kidney disease. This study examined the relationships between Metabolic and bariatric surgery and adverse kidney outcomes. This retrospective cohort analysis included 4322 patients with obesity, with or without type 2 diabetes mellitus (T2D), who underwent Metabolic and bariatric surgery, and 30,919 nonsurgical control patients from a large health system within the state of Indiana. A primary kidney composite [≥ 1 estimated glomerular filtration rate (eGFR) < 15 mL/min/1.73 m2, ≥ 1 eGFR measurement with a ≥ 40% decrease from baseline, or kidney failure-related death], as well as secondary and tertiary composite and individual outcomes, were assessed. Multivariable Cox regression models with and without inverse propensity of treatment weighting were employed to assess associations between Metabolic and bariatric surgery and incidence rate for each kidney outcome compared with nonsurgical controls.
Results: The mean (standard deviation) follow-up duration was 6.1 (4.5) years. Metabolic and bariatric surgery was associated with a 53% (HR: 0.47; 95% CI: 0.42, 0.52; p < 0.001) and 48% (HR: 0.52; 95% CI: 0.46, 0.60; p < 0.001) lower incidence of the primary kidney composite outcome in patients with and without type 2 diabetes, respectively, and 48%–56% lower risks for the secondary and tertiary outcomes, regardless of type 2 diabetes status, compared to controls.
Metabolic and bariatric surgery was associated with markedly lower risks for adverse kidney outcomes in patients with obesity. These results support the potential for Metabolic and bariatric surgery as a weight loss intervention to preserve kidney function in patients with obesity, both with and without type 2 diabetes.
Reference:
Maki, Kevin C., Stephanie L. Dickinson, Carol F. Kirkpatrick, et al. 2025. “ Relationships Between Metabolic and Bariatric Surgery and Adverse Kidney Outcomes: An Analysis of a Retrospective Cohort,” Obesity Science & Practice: e70109. https://doi.org/10.1002/osp4.70109.
Keywords:
Bariatric, Surgery, Linked, Lower, Risk, Adverse, Kidney, Outcomes, Study, Maki, Kevin C., Stephanie L. Dickinson, Carol F. Kirkpatrick
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.